There is no science here, just marketing
Clinical trial data specifically examining tirzepatide's effects on menstrual cycles and reproductive hormones remain limited
Disclosures: Ana Maria Davila Morales: Nothing to Disclose, Nancy Reau: Gilead: Grant/Research Support, eiger: Grant/Research Support, abbott: Consultant, Arbutus: Consultant, Gilead: Consultant, VIR: Consultant, Salix: Consultant, Salix: Grant/Research Support, AbbVie: Grant/Research Support, Zoe Post: Nothing to Disclose, Kesany Boupapanh: Nothing to Disclose 2337 HISTOLOGICAL STAGE AS PREDICTOR OF THE COMPLICATIONS OF PRIMARY BILIARY CHOLANGITIS Tadashi Namisaki 1 Yukihisa Fujinaga 2 Shinya Sato 2 NORIHISA NISHIMURA 2 KOSUKE KAJI 2 Hitoshi Yoshiji 2 , 1 Na, 2 Nara Medical University Background: This study aimed to clarify the predictive ability of histological stage (HS) in comparison with biochemical response to ursodeoxycholic Acid (UDCA) (BR) for the development of complications in patients with primary biliary cholangitis (PBC)

A 2025 survey conducted by the Kinsey Institute at Indiana University with DatingAdvice.com found that men were more likely to feel stigma about taking GLP-1 medication as compared to women
doi:10.1038/srep14634 39
They also estimated the hormone secretion during this period